Purchase made under the Authority of Texas Government Code 2155.144 for goods or services acquired for the benefit or on behalf of clients of programs…

Merck Sharp & Dohme Corp. was awarded contract HHSTX-7-0000416147 by the State of Texas on October 6, 2026, under the authority of Texas Government Code Section 2155.144 for the procurement of pharmaceutical products and vaccines to support state agency clients and program beneficiaries. The contract encompasses multiple therapeutic categories including immunomodulating drugs based on tyrosine and kinase inhibitors, hyaluronic acid-based products, diphtheria and tetanus vaccines with whole-cell pertussis components, tolvaptan, and thymalfasin. These products fall under the National Institute of Governmental Purchasing classification for serums, toxoids, and vaccines.

The procurement was executed in conjunction with Federal Contract Number 75D30126D20729 and is classified under Texas Government Code Section 771. While specific contract value figures, annual pricing, cumulative value, and the detailed performance period are not provided in the award documentation, the contract structure indicates this is a statewide pharmaceutical supply agreement designed to provide medications and immunological agents to beneficiaries of state-operated healthcare programs administered by the Texas Health and Human Services Commission or affiliated agencies.